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Abstract 
Minimal research is available pertaining to the suspected acute cardiac injury of cattle 
experiencing the early signs of respiratory disease.  One of the limitations of cardiac disease 
diagnosis in cattle is the lack of accurate measurement of cardiac disease.  Blood biomoarkers 
such as cardiac troponin I could be used.  Cardiac troponin I is a serum biomarker for cardiac 
injury in humans and many veterinary species.  The goal of this thesis is to evaluate biophysical 
changes including cardiac injury that holstien calves experience during acute pneumonia.  The 
first objective of this research was to evaluate a point of care cardiac troponin I assay for use in 
the bovine.  Purified bovine cardiac troponin I was used to validate the accuracy of the assay 
over a wide range of concentrations in an in vitro experiment.  This point of care assay was 
capable of accurately identifying bovine cardiac troponin I.  An in vivo experiment was 
conducted to evaluate concentrations of cardiac troponin I in healthy Holstein calves.  
Concentrations evaluated with the point of care assay were similar to concentrations of a 
previously validated immunoassay.  The second objective was to evaluate biophysical changes 
including serum biochemistry, complete blood count, cardiac troponin I, and high resolution 
digital thermography in Holstein calves during the first fourteen days after induction of 
pneumonia.  Fibrinogen concentration increased with lung disease severity.  The changes 
observed were considered clinically significant.  Cardiac troponin I increased as pneumonia 
progressed during the study in this population.     
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Chapter 1: Thesis Introduction 
Cardiac disease in cattle remains a challenging diagnosis and may represent a poor to 
guarded prognosis.  Heart failure is the result of cardiac disease that cannot be compensated with 
cardiac and neurohormonal mechanisms.  Cardiac disease may occur as a primary disease or may 
be secondary to another etiology in cattle.  Diagnostic tests that establish accurate identification 
of cardiac disease may allow more prompt treatment or salvage of affected cattle.   
Traditional methods of evaluating BRDC in cattle such as behavior scores and rectal 
temperature may be less than ideal for an accurate diagnosis. (Griffin et al 2010)  Thoracic 
auscultation is another commonly utilized method of evaluating cattle pneumonia. Further 
diagnostic tests including ultrasonography and radiology are not always available or practical for 
every animal suspected of having BRDC.  Biophysical profiling of calves experiencing 
respiratory disease may identify biomarkers which may provide a more accurate diagnosis, 
disease severity and prognosis.  
Cardiac disease in cattle may present due to a variety of disease conditions.  In Chapter 2 
a review of literature is presented.  Chapter 2 offers a review of cardiac disease etiologies 
devided among anatomical locations with a focus on cardiac disease associated with respiratory 
disease known as cor pulmonale.  Cor pulmonale in cattle is typically associated with two main 
etiologies of respiratory compromise.  These two main etiologies include bovine high mountain 
disease and chronic pneumonia.  Bovine high mountain disease results in cor pulmonale from a 
low atmospheric oxygen pressure leading to vasoconstriction of the pulmonary vasculature 
which ultimately results in right sided heart failure.  Chronic pneumonia results in cor pulmonale 
due to loss of functioning lung parenchyma and changes in vascular flow leading to an increased 
workload on the right heart, ultimately leading to heart failure.  There is no available literature 
regarding cattle with acute respiratory disease and cardiac injury.             
Cor pulmonale associated with chronic respiratory disease respresents a gaurded 
prognosis for cattle.  With increased knowledge of potential cardiac insults associated with early 
respiratory disease veterinarians may be able to offer a more accurate prognosis for respiratory 
disesase.  Evaluation of mild cardiac disease in cattle is often not readily accomplished because 
many veteriarians due not have access or are financially limited by advanced diagnostic tests 
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while evaluating cattle.  These diagnostic tests may include echocardiaography, 
electrocradiography, or thoracic radiographs.  An inexpensive, portable diagnostic test may be 
valuable to veterinarians to evaluate cardiac disease in cattle.     
A study in this thesis (Chapter 3) evaluated cardiac troponin I in, in vivo and in vitro 
models. Cardiac troponin I (cTnI) has been established as the gold standard for evaluating 
myocardial disease in humans because of rapid results, and specificity for myocardium. (O’Brien 
2008 and Hasić et al. 2003)  This diagnostic test has gained wide use in veterinary species.  In 
both humans and veterinary patients, cTnI has been shown to increase with cardiac and extra 
cardiac thoracic disease including pneumonia.  Cardiac troponin has been shown to be increased 
in several disease conditions of cattle.  These studies suggest cardiac injury of cattle from direct 
cardiac insult and systemic diseases.      
Diagnosis and providing an accurate prognosis of subclinical bovine respiratory disease 
in difficult.  Evaluation of specific multiple measurements at once may aid in increasing the 
ability to differentiate calves that are experienceing severe or mild pneumonia.  Measurements 
including components of a complete blood count and biochemistry in addition to high resolution 
digital thermography, and cardiac troponin I were evaluated as a part of this thesis.  These 
combined individual measurements may be stated as a biophysical profile.     
In this thesis (Chapter 4) Holstein calves were evaluated for biophysical changes 
experiencing induced Mycoplasma bovis pneumonia.  The components of a biophysical profile 
were analyzed to identify differences between calves that experienced severe and mild 
pneumonia.  These compenents were evaluated the day of induction in the middle of the 
respiratory disease and at the conclusion of the study.  At the conclusion the calves were 
euthanized and each lung received a visual grade for the percent of diseased lung.  This scoreing 
of the lungs was used to determine if the calves would be classified as experiencing mild or 
severe disease for data analysis.   
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Chapter 2 - Review of Literature 
 Introduction 
Bovine respiratory disease is a multifactorial disease process that involves several 
etiologic agents resulting in disease of the bovine respiratory system. (Confer 2009, Apley 2006, 
and Allen et al. 1992)  The United States cattle industry experiences a significant financial and 
death loss impact from BRDC.  Despite continued research, more treatment options, and 
improved knowledge of pathophysiology, treatment of BRDC is not always successful. Cardiac 
injury as a result of BRDC may be a significant component of the disease syndrome.  
 Bovine Respiratory Disease Complex 
Diagnosis and treatment of bovine respiratory disease complex remains challenging.  
Diagnosis of respiratory disease is most often made from subjective evaluation of cattle with 
respiratory disease. (Griffin et al 2010)  Several studies have evaluated more objective 
measurements to improve the accuracy of diagnosis of bovine respiratory disease complex. 
Routine laboratory variables are not reliable indicators of lung involvement or the 
progression of pneumonia in cattle. (Hanzlicek et al 2010)  Behavioral data may aid in 
identifying cattle affected with bronchopneumonia. (Hanzlicek et al 2010)  Prompt identification 
of sick cattle is of great concern and signs may be masked from caretakers for a considerable 
amount of time due to the prey behavior that cattle present when ill. (Griffin et al. 2010)   Onset 
of clinical signs of respiratory disease are typically not identified in cattle with respiratory 
disease until 7-10 days and up to 27 days after a stressful event. (Duff et al. 2007)  Clinical 
observations are commonly used by cattle caregivers to identify the individuals suffering from 
pneumonia or other disease.  These observations alone have questionable accuracy and may not 
be consistent between health care providers.  Clinical observations have been shown to have 
limitations for accurate detection of BRDC calves with estimated sensitivity of 62% and 
specificity of 63%. (White et al. 2009)  Rectal temperature, heart rate and respiratory rate may 
yield conflicting results, and may vary with time of day. (Hanzlicek et al. 2010)   Considerable 
disagreement among veterinarians is present when evaluating calves for respiratory disease. 
(Amrine et. al. 2013)  
4 
 
The majority of the available literature focuses on the effect of BRDC on the respiratory 
system. Involvement of the cardiovascular system receives little attention in BRDC research. 
There are specific bovine respiratory disease pathogens that cause disease to the cardiac system.  
Histophilus somni is well known to cause myocarditis and myocardial infarction in addition to its 
contribution to BRDC. (Orr 1992) M. bovis has been isolated from the bovine heart alone and in 
conjunction with H. somni (Maunsell et al 2011), though does not typically cause gross or 
histological changes which may indicate a commensal role of M.bovis.  Specific respiratory 
pathogens may have result in direct injury to the cardiac system in addition to more general 
insult to the heart from increased vascular resistance and increased right heart work.     
Diagnosis of BRDC remains a chalenging endevor.  Evaluation of more objective 
measurement of clinical illness scores and behavior have not yielded a highly accurate diagnosis 
of BRDC.  More objective evaluation of laboratory components have also not resulted in an 
accurate diagnosis of BRDC.  More accurate diagnosis and prognosis may continue to further the 
ability to identify and treat BRDC.  Knowledge of cardiac injury as a result of respiratory disease 
in cattle may offer a more accurate prognosis.   
 Cardiac Disease Etiologies 
Various components of the bovine heart may become injured through different disease 
states.  The three main structures of the bovine heart that are commonly affected by disease 
include: the pericardium, the myocardium, and the endocardium including valvular disease.  
Disease of the conductive tissues are infrequent in the bovid. (Machida et al. 2005)    
Traumatic reticulopericarditis is the most commonly reported pericardial disease of 
cattle. (Braun et al 2007, Roth et al. 1991) Other pericardial diseases of cattle described in one 
report in descending order of number of reported cases include; pericarditis secondary to pleural 
or lung infection, neoplastic effusion secondary to a lymphoma or mesothelioma and idiopathic 
aseptic pericarditis. (Buczinski et al. 2010)   
In one study, dilated cardiomyopathy is the most common primary myocardial disorder 
of cattle. (Nart et al. 2004)  Myocarditis, a secondary myocardial disease, may result from viral, 
bacterial, and parasitic infection. (Gunes et al. 2005, Uzal et al., 2003, and Otter et al. 1995)  
Nutritional cardiomyopathy may be caused by deficiencies of vitamin E, selenium, or copper, 
(Orr et al. 1996, and Leigh 1975) in addition to toxicity of ionophores. (Van Vleet et al 1983)  
5 
 
Cor pulmonale, secondary to pulmonary hypertension, as a result of reflex pulmonary arteriolar 
vasoconstriction, fibrosis and pulmonary injury is associated with right heart failure in cattle.  
Pulmonary hypertension may be caused by decreased oxygen partial pressure from pulmonary 
disease or high altitude. (Holt et al 2007)   
Bacterial endocarditis is the most common endocardial disease of bovids. (Buczinski et 
al. 2010)  The main etiologies include Truperella pyogenes and streptococci with the right 
atrioventricular valve being the most commonly affected. (Buczinski et al. 2010)  Endocarditis 
may also be a result of turbulent blood flow striking the endocardium causing fibrosis and 
roughening known as jet lesions due to valvular dysplasia (Watson et al. 1991) or cardiac 
implantation during research scenerios. (Fossum et al. 2001) 
Numerous congenital cardiac abnormalities have been reported in the bovid.  Ventricular 
septal defects are the most commonly reported. (Buczinski et al. 2010)  Other reported defects 
include atrial septal defects, patent ductus arteriosis, tetralogy or pentology of fallot, and 
Eisenmenger’s complex. 
Cardiac disease in cattle is represented by a variety of pathophysiology.  The veterinarian 
must evaluate the cardiac system to identify what anatomical components are affected to form 
differential diagnosis’s.  Each disease etiology is not exclusive and the individual animal may 
have multiple etiologies present.   
 Cardiac Injury in Cattle 
 
Diagnosis of cardiac injury prior to heart failure is challenging.  Initially, cardiac 
auscultation is used to assess the heart for problems such as murmurs, arrhythmias, and other 
abnormal heart sounds.   Arrhythmias may be further evaluated utilizing electrocardiography.  
The most common dysrhythmia of cattle is atrial fibrillation, and can only be confirmed with 
electrocardiography. (Buczinski et al. 2010)  Physiologic and pathologic murmurs may be 
differentiated with aid of echocardiography.  Thoracic radiographs are utilized to identify 
metallic foreign bodies associated with traumatic reticulopericarditis. (Buczinski et al. 2010)  
One study noted that thoracic radiographs are useful in cases of congenital heart disease in 
calves. (Farrow et al. 2000)  Measurement of the caudal vena cava with thoracic radiographs has 
been noted as a reliable tool for detecting heart disease in cattle. (Jilintai et al. 2006)  Thoracic 
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radiographs have shown to be of minimum utility for evaluating an increase of cardiac silhouette 
with bovid heart disease. (Buczinski et al. 2006a and Buczinski et al. 2006b)   
Several blood biomarkers may be increased in association with cardiac disease to include: 
creatine phosphokinase, lactate dehydrogenase, cardiac troponin T, and cardiac troponin I.  The 
gold standard biomarker for myocardial injury in humans is cardiac troponin I. (O’Brien 2008 
and Hasić et al. 2003)  Cardiac troponin T and cardiac troponin I have received more evaluation 
in bovine research that has been recently published. (Varga et al. 2009a, Varga et al. 2009b, 
Mellanby et al. 2009, Gunes et al. 2008, Peek et al. 2008, Mellanby RJ et al. 2007, and Gunes et 
al. 2005)  A variety of assays have been implemented in studies evaluating bovine cTnI.  The 
only validated assessment of bovine cardiac troponin I is a bench top immunoassay. (Varga et al. 
2009a)  
Heart failure is a condition when the heart can not pump an adequate blood supply to the 
rest of the body.  The neurohormanal system attempts to compenstate through myocardium 
hypertrophy, tachycardia and systemic vasoconstriction. Clinical findings in one report of heart 
failure in the bovid include in descending order: tachycardia, abnormal heart sounds, jugular 
distention, peripheral edema, jugular pulse, ascites, cough, and syncope. (Buczinski et al. 2006b) 
 Cor Pulmonale in Cattle 
Cor pulmonale in cattle can be a result of chronic respiratory disease. (Angel et al. 1992, 
and Jubb et al. 1992)  Respiratory disease continues to be a concern representing a significant 
cause of economic and animal loss. Early recognition of BRDC can result in more rapid 
therapeutic implementation. (Apley, 2006)  There is currently not a highly accurate method 
available for establishing an ante-mortem diagnosis of bovine pneumonia and case definitions 
can vary significantly. (Apley 2006)  Ante-mortem diagnosis of BRDC is typically made from 
observations.  The most common observations used for diagnosis are depression, appetite loss, 
respiratory character change, and temperate elevation. (Griffin et al. 2010)  A hypothesis is that 
improved accuracy of prognosis may be obtained through evaluation of concurrent cardiac 
injury.  Continued research efforts are needed to improve early diagnosis and establish improved 
prognosis of cattle suffering from BRDC. 
Chronic respiratory disease can lead to a syndrome known as cor pulmonale. (Angel et al. 
1992, and Jubb et al. 1992)  The increased cardiac workload in humans is responsible for the 
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right ventricular hypertrophy and eventual congestive heart failure. (Summer et al. 1978) 
Alveolar hypoxia, acidosis, increased blood viscosity, increased pulmonary blood flow or an 
anatomic reduction of the pulmonary vasculature bed to include empthsema and pulmonary 
emboli may cause contraction of the precapillary pulmonary vessels leading to increased 
vascular resistance. Pulmonary hypertension occurs as a result of increased vascular resistance 
and thus increases the cardiac workload.  This increased cardiac workload can lead to cardiac 
injury.  Cor pulmonale as a result of respiratory disease is often not diagnosed until the 
individual is experiencing heart failure.  Little research is available which describes the effects of 
respiratory disease on the bovid cardiac system.  Bovine high mountain disease is another 
mechanism that can result in cor pulmonale in cattle.  The individual experiences lower 
atmospheric pressures at high altitude leading to pulmonary hypertension.  Pulmonary artery 
pressure testing can aid in these diagnoses. (Holt et al 2007)  Bovine high mountain disease 
results from hypoxia leading to pulmonary vasoconstriction, pulmonary remodeling, pulmonary 
hypertension, and finally right heart failure resulting clinically in brisket edema.   
Conditions that may induce alveolar hypoxia include; exposure to high altitude, 
pneumonia, respiratory impairment secondary to chest wall abnormalities, airway obstruction, 
pulmonary edema, emphysema or increased pulmonary vascular disease.  Lower ambient 
temperatures will also increase pulmonary artery pressures in cattle. (Will et al. 1978)  This may 
exacerbate concurent respiratory disease. Polycythemia resulting in increased blood viscosity 
may exacerbate pulmonary hypertension and lead to a continued injury to the cardiac system.  
The cardiopulmonary system of cattle may be insulted in various methods or a combination of 
methods resulting in fulmonant cor pulmonale.   
Pneumonia is a common condition in cattle leading to significant respiratory impairment 
and failure.  In a chronic state this will lead to a clinical condition of right sided heart failure 
known as cor pulmonale.  (Angel et al. 1992, and Jubb et al. 1992) Pulmonary tissue fibrosis and 
necrosis may cause pulmonary blood shunting and release of vasoactive facotrs such as atrial 
natriuretic peptide.  The alveolar hypoxia that pneumonia induces leads to pulmonary artery 
hypertension.  This extra work load on the heart does predictably induce cardiac injury.  The 
heart is continually injured and must remodel and compensate for the increased work load due to 
hypertension.  Cardiac hypertrophy occurs as the result of continued pulmonary hypertension 
from chronic alveolar impairment due to respiratory disease. 
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Limited literature is available concerning the contribution of respiratory disease to cor 
pulmonale in cattle. (Angel et al. 1992, and Jubb et al. 1992)  The literature of respiratroy disease 
induced cor pulmonale is retrospective in nature. (Angel et al. 1992, and Jubb et al. 1992)  No 
literature is availible concerning the injury the bovine heart may experience during early 
respiratory disease.  Increased cardiac work load may result in cardiac injury during respiratory 
disease.  The utility of cardiac biomarkers may aid in the classification of cardiac injury during 
the early stages of BRDC.     
 Bovine High Mountain Disease 
High mountain disease of cattle is a common condition in cattle living at high altitudes 
greater than 5000 feet above sea level that results in cor pulmonale. (Holt et al. 2007)  The 
disease process of bovine high mountain disease may allow a greater understanding of the less 
documented process of chronic respiratory disease resulting in cor pulmonale.  The high altitude 
results in low atmospheric pressures of oxygen.  This results in an alveolar hypoxia which leads 
to continued pulmonary vessel contraction and develops into pulmonary hypertension.  The 
fulminant disease classically results in cattle with distended pulsating jugular veins and brisket 
edema.  Disease is typically evaluated with pulmonary artery pressure testing, objectively 
measuring the degree of hypertension.  Cattle at risk of developing bovine high mountain disease 
will have a pulmonary artery pressure greater than 45 millimeters of mercury.  The common 
recommendation is for the movement of the animal to a lower altitude. (Holt et al. 2007)  
Any concurrent illness that causes a temporary or permanent pulmonary hypoxia can lead 
to an increased pulmonary artery pressure. (Holt et al. 2007, Angel et al. 1992, and Jubb et al. 
1992)  Thus high mountain disease can be exacerbated with concurrent illness.  Noxious plants 
known as locoweeds increase the risk of heart failure in cattle susceptible to the effects of high 
altitudes. (Knight et al. 2001)  A genetic component likely exists that predisposes cattle to the 
development of high mountain disease. (Holt et al. 2007)  Selection of cattle to remain or enter a 
herd may be aided with pulmonary artery pressure testing.     
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 Cardiac Troponin I in Veterinary Medicine 
Injury to the cardiovascular system can be evaluated with various biomarkers.  Cardiac 
troponin I has been extensively utilized in human and veterinary medicine as a biomarker for 
cardiac injury. (Blass et al. 2011, Payne et al. 2011, Varga et al. 2009a, O’Brien 2008, O'Brien 
PJ et al 2006, Slack et al. 2005, and O'Brien et al 1997)  This biomarker is a likely candidate for 
the evaluation of myocardial injury from pneumonia induced pulmonary hypertension in cattle.  
Pulmonary hypertension will increase the workload experienced by the right heart inducing 
mycardial injury and remodeling.     
Cardiac troponin I has been used extensively in veterinary medicine as a biomarker for 
cardiac injury.  Cardiac troponin I (cTnI), a myofibril protein that regulates contraction of the 
myocardium, is currently considered the gold standard diagnostic test for cardiac injury in 
humans. (O’Brien 2008 and Hasić et al. 2003) Cardiac injury of humans has been indentifed by 
increases in cardiac troponin in a variety of non cardiac diseases to include; chronic obstructive 
pulmonary disease, community-acquired pneumonia, acute lung injury or the acute respiratory 
distress syndrome after subarachnoid hemorrhage, and septic shock.  (Monaghan et al. 2012, 
Moammar et al. 2010, Naidech, et al. 2009, and Oliveira et al 2008)  
Cardiac troponin has been used as a biomarker of cardiac injury in a variety of diseases in 
a variety of species.  In dogs it has been shown to be useful in differentiating cardiac and non-
cardiac disease as a cause of acute respiratory distress. (Payne et. al. 2011)  Specifically dogs 
with cardiac conditions including right ventricular cardiomyopathy have demonstrated increases 
in serum cTnI. (Baumwart et al 2007)  Dogs with extra thoracic conditions that increase cardiac 
workload such as gastric dilatation-volvulus have been shown to have an increase in cTnI 
concentrations. (Schober et al. 2002)  Cardiac troponin I has also been demonstrated to be an 
accurate indicator of cardiac injury with feline hypertrophic cardiomyopathy. (Herndon et al. 
2002)  Cardiac troponin has been shown to be a useful biomarker for cardiac injury in several 
veterinary species.  
Cardiac troponin has been proven to be an accurate biomarker for cardiac injury in large 
animals as well.  A study demonstrated increased cardiac troponin protein in an equid as a 
response to feed contaminated with ionophore due to myocardial injury. (Schwarzwald et al 
2003)  Cardiac troponin has also been shown to be higher in septic foals when compared to non-
septic foals. (Slack et al. 2005)  This may have been form vascular changes or direct bacterial or 
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toxin effects on the heart representing that cTnI may detect indirect cardiac injury.  A human 
cardiac troponin assay recently was able to successfully calculate a concentration of cardiac 
troponin I in healthy alpacas. (Blass et al 2011)  
Cardiac troponin I has been used extensively in research and clinical cases within the 
literature regarding cattle representing a variety of disease states.  Foot and mouth disease has 
caused cardiac injury based upon an increase of cTnI as compared to controls. (Gunes et al. 
2005)  Cardiac troponin may lack specificity for direct cardiac injury and may increase with 
systemic disease that causes changes in vascular dynamics that result in increased cardiac work 
and injury.  Diseases known to cause cardiac injury of bovids have also been shown to result in 
an increase cTnI.  These conditions include monensin toxicosis (Varga et al. 2009b), idiopathic 
pericarditis (Jesty et al. 2005), traumatic reticulopericarditis (Gunes et al. 2008 and Mellanby et 
al 2009), and endotoxemia. (Peek et al 2008)  Cattle that suffer from chronic suppurative 
pneumonia have been shown to have higher cTnI concentrations as compared to controls. 
(Mellanby et al. 2009)  Cardiac troponin changes have not been reported in acute bovine 
respiratory disease.  All of these studies utilized various human cardiac troponin diagnostic 
testing devices.  There is over 96% homology of human and bovine cardiac troponin I. (O’Brien 
et al 1997) The similar protein structure of cardiac troponin demonstrates that human assays for 
cTnI should be able to successfully identify cardiac troponin in cattle plasma.  Each assay should 
be evaluated for the intended species of application.  A variety of diseases and conditions in 
cattle have resulted in an increased cTnI concentration.  This represents a wide range of disease 
where cardiac injury is present.  Cattle with pneumonia likely will have pulmonary hypertension 
and thus experience cardiac injury.  Cardiac troponin I may be a sensitive and accurate 
biomarker to identify cardiac injury in cattle.  
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Chapter 3 - Assessment of a commercially available point-of-care 
assay for the measurement of bovine cardiac troponin I 
As accepted by the American Journal of Veterinary Research: 
 
 Abstract 
 
Objective—To assess a commercially available point-of-care assay for measurement of 
bovine cardiac troponin I (cTnI) in blood and plasma samples. 
Sample—Prepared bovine plasma standard samples with known concentrations (0 to 1.0 
ng/mL) of cTnI and blood and plasma samples obtained from 28 healthy 2.5-month-old Holstein 
calves. 
Procedures—Coefficients of variation were calculated for concentrations of cTnI in 
prepared standards determined with the point-of-care assay and values were compared with the 
known concentrations. The cTnI concentrations in blood samples obtained from calves determined 
with the point-of-care assay were compared with cTnI concentrations in plasma samples obtained 
from those animals determined by use of a validated immunoassay. 
Results—The coefficients of variation of cTnI concentrations determined for prepared 
standards by use of the point-of-care assay were low (< 20%) for standards with cTnI concentrations 
of ≥ 0.025 ng/mL. The blood cTnI concentrations determined with the point-of-care assay were not 
significantly different from the plasma cTnI concentrations determined with the validated 
immunoassay.   
Conclusions and Clinical Relevance—Results of this study indicated the point-of-care 
assay had high precision for determination of cTnI concentrations in most evaluated prepared bovine 
plasma standard samples. The point-of-care assay may be useful for determination of circulating 
concentrations of cTnI for cattle. 
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 Introduction 
Measurement of concentrations of cTnI, a myofibril protein that regulates contraction of 
myocardium, is considered the gold standard diagnostic test for detection of cardiac injury in 
humans. (O’Brien et al. 2008 & Hasic et al. 2003)  There is > 96% homology between cTnI of 
humans and that of cattle (O’Brien et al. 1997); therefore, antibodies against human cTnI in 
commercially available assays are expected to cross-react with bovine cTnI. Cardiac troponin 
has been used as a biomarker of cardiac injury attributable to various diseases in dogs, cats, and 
horses. (Serra et al. 2010, O’Brien et al. 2006, Payne et al. 2011, Schober et al. 2002, Baumwart 
et al. 2007, Herndon et al. 2002, Schwarzwald et al. 2003, and Slack et al. 2005)  Also, cTnI 
concentration increases during various diseases of cows, including idiopathic pericarditis, (Jesty 
et al. 2005) traumatic reticulopericarditis, (Gunes et al. 2008, and Mellanby et al. 2007) foot and 
mouth disease, (Gunes et al. 2005) monensin toxicosis, (Varga et al. 2009b) and experimentally 
induced endotoxemia. (Peek et al. 2008)   Results of another study (Mellanby et al. 2009) 
indicate that cattle with various cardiac diseases or non-cardiac intrathoracic diseases have high 
serum cTnI concentrations, compared with concentrations for healthy control animals. 
Recently, a benchtop immunoassay has been validated for measurement of bovine cTnI 
concentrations. (Varga et al 2009a)  Although that assay is not portable, it could be used to 
evaluate the accuracy of a point-of-care diagnostic assay for measurement of bovine cTnI 
concentrations in field settings. A commercially available point-of-care device and disposable 
cartridge have been used to measure plasma cTnI concentrations for animals including dogs, 
(Payne et al. 2011) alpacas, (Blass et al. 2011) and horses. (Kraus 2009) The objective of the 
study reported here was to determine the repeatability of results of a point-of-care diagnostic test 
for determination of cTnI concentrations in plasma samples obtained from calves and to compare 
results with those determined by use of a previously validated diagnostic test. (Varga et al 2009a) 
 
We hypothesized that the point-of-care diagnostic test would detect bovine cTnI and the test 
would be precise for measurement of cTnI concentrations.  
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 Materials and Methods 
Samples— Various concentration For determination of point-of-care cTnI assay 
precision, standards with various concentrations of cTnI were prepared with bovine plasma 
obtained from a university owned, healthy mature cross bred cow, for determination of point-of-
care cTnI assay precision,.  In addition, blood and plasma samples were obtained from 28 
healthy Holstein calves (approx age, 2.5 months) for cTnI testing.  ; whole blood sample cTnI 
concentrations determined by use of a point-of-care assay were compared with plasma cTnI 
concentrations determined by use of a validated immunoassay.  Calves were comingled from 
multiple sources in Iowa and purchased as a group.  Calves were housed together in a pen (25 X 
25 m) outdoors during the study. The study protocol was approved by the Kansas State 
University animal care and use committee.  
Point-of-care cTnI assay precision—The precision of a commercially available point-of-
care device (i-STAT 1 portable clinical analyzer, Abaxis North America, Union City, CA) and 
disposable cartridge (i-STAT cTnI cartridge, Abaxis North America, Union City, CA) was 
determined via measurement of various cTnI concentrations in standards prepared with bovine 
plasma containing lithium heparin and purified bovine cTnI. (Purified bovine cTnI: Life 
Diagnostics, West Chester Pennsylvania)  The assay was repeated 3 times for standards without 
cTnI (cTnI concentration, 0 ng/mL [negative control sample]) and 5 times for standards with 
various concentrations of cTnI. (1, 0.5, 0.25, 0.1, 0.05, 0.025, and .01 ng/mL) Precision of the 
assay for measurement of cTnI concentrations in bovine plasma was determined via calculation 
of coefficient of variations (CV).  
Comparison of cTnI point-of-care assay results with immunoassay results—Results 
obtained with a point-of-care assay (i-STAT 1 portable clinical analyzer, Abaxis North America, 
Union City, CA) and disposable cartridge (i-STAT cTnI cartridge, Abaxis North America, Union 
City, CA) were compared with those obtained by use of a validated (Varga et al 2009a) 
immunoassay (ADVIA Centaur TnI-Ultra, Siemens Medical Solutions Diagnostics, NY) for 
measurement of cTnI in whole blood and plasma samples obtained from calves. A venous blood 
sample (2 mL) was collected from a jugular vein of each calf into a tube containing lithium 
heparin by use of a 1.5-inch X 20-gauge needle. Whole blood samples were analyzed for 
determination of whole blood cTnI concentrations once with the point-of-care assay (i-STAT 1 
portable clinical analyzer, Abaxis North America, Union City, CA) and disposable cartridge (i-
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STAT cTnI cartridge, Abaxis North America, Union City, CA) on the same day of sample 
collection. (i-STAT 1 portable clinical analyzer, Abaxis North America, Union City, CA)  Then, 
each sample was centrifuged (2,350 X g) for 10 minutes at 22°C, plasma was harvested, and 
plasma samples were stored at –80°C for up to 14 days until determination of cTnI 
concentrations by use of a validated (Varga et al 2009a) immunoassay (ADVIA Centaur TnI-
Ultra, Siemens Medical Solutions Diagnostics, NY); results of another study
 
(Varga et al 2009a) 
indicate cTnI concentrations do not decrease in bovine plasma samples stored at –80°C for 14 
days.  
 Data and Statistical Analysis 
Precision of the point-of-care assay for determination of cTnI concentrations in prepared 
bovine plasma standards was determined via calculation of CVs. A 1-sample t test was used to 
identify differences between known and measured concentration means. Outlier values were 
defined as values > the 99th percentile value of the mean value for each known cTnI 
concentration.
 
(Abbott point of care website. http://www.abbottpointofcare.com/ Cardiac 
troponin /(cTnI) Cartridge and Test Information Sheets, 2012); such data (1 value each for 0.01 
and 0.05 ng/mL cTnI concentration standards) were attributed to faulty cartridges and were not 
included in the statistical analysis. The whole blood cTnI concentration values determined by use 
of the point-of-care assay for calves were compared with plasma cTnI concentrations determined 
by use of the validated immunoassay for those animals via a Student t test for paired data. For 
statistical analysis, plasma cTnI concentration values determined by use of the immunoassay that 
were < 0.01 ng/mL were considered to be 0 ng/mL. Values of P < 0.05 were considered 
significant. All analyses were performed with commercially available computer software. (Excel 
for Mac. 2008. Microsoft Corporation, Redmond Washington) 
 
 Results 
Point-of-care cTnI assay precision—The cTnI concentrations determined by use of the 
point-of-care assay were typically higher than the known concentrations of cTnI in prepared 
bovine plasma standards (Table 1); values were significantly different for all cTnI concentration 
standards except the 0.01 ng/mL standard. However, the CV for the point-of-care assay was < 
20% for all prepared bovine plasma cTnI standards except for the lowest cTnI concentration. 
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(0.01 ng/mL; CV, 38%) Concentrations of cTnI in negative control samples determined by use of 
the point-of-care assay were 0 ng/mL for all 3 repeated tests; therefore, use of the bovine plasma 
as a diluent for the cTnI concentration standards was considered appropriate. 
Comparison of cTnI point-of-care assay results with immunoassay results—The cTnI 
concentrations in whole blood samples determined by use of the point-of-care assay mean ± SD, 
0.01 ± 0.01 ng/mL; median, 0 ng/mL; range, 0 to 0.04 ng/mL) were similar to plasma 
concentrations determined by use of the validated immunoassay. (mean ± SD, 0.006 ± 0.006 
ng/mL; median, 0.01 ng/mL; range, 0 to 0.02 ng/mL) (mean ± SD, 0.01 ± 0.01 ng/mL; median, 0 
ng/mL; range, 0 to 0.04 ng/mL)  Results of statistical analysis performed with a Student t test for 
paired data indicated concentrations determined via the 2 assays were not significantly different. 
Of the 28 whole blood and harvested plasma samples, 12 (43%) had identical cTnI concentration 
test results, 13 (46%) had a concentration difference of 0.01 ng/mL between the 2 tests, 2 (7%) 
had a concentration difference of 0.02 ng/mL between the 2 tests, and 1 (4%) had a concentration 
difference of 0.03 ng/mL between the 2 tests. 
 Discussion 
The results of this study suggested that the point-of-care assay may be appropriate for 
determination of concentrations of cTnI in blood samples obtained from cattle. This point-of-
care assay has been used to measure circulating cTnI concentrations for healthy alpacas
20
; 
however, investigators of that study could not validate the test for that species because purified 
alpaca cTnI was not available. The point-of-care assay was validated for measurement of bovine 
cTnI in the present study via testing of standards prepared with bovine plasma and purified 
bovine cTnI. To obtain accurate results with this assay, whole blood samples must be collected 
into tubes containing lithium heparin. Initially, we attempted to prepare cTnI standards with 
bovine plasma containing acid-citrate-dextrose solution, but results had high variability and cTnI 
concentrations were markedly lower than the known concentrations in standard samples. 
Conclusions of this study may have been stronger if high cTnI concentrations had been detected 
in blood and plasma samples; this would have necessitated obtaining blood samples from cattle 
with myocardial disease. Cattle with myocardial disease were not available for use in this study, 
and induction of cardiac injury in calves was not feasible. Future research is warranted to 
determine the clinical usefulness of the point-of-care assay for measurement of high 
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concentrations of cTnI in blood samples obtained from cattle. On the basis of results of this 
study, we concluded that clinicians would be unlikely to misdiagnose myocardial injury for 
calves with low cTnI concentrations. Further research is warranted to determine the likelihood 
that cattle with myocardial injury would have clinically normal cTnI concentrations as 
determined by use of the point-of-care assay.  
Results of other studies (O’Brien et al. 1997 and Varga et al 2009a) indicate cTnI assays 
have minimal cross-reactivity with proteins in noncardiac bovine muscle homogenates; these 
results suggest that assays for measurement of bovine cTnI are likely specific for myocardial 
proteins. In the present study, we used an immunoassay and a point-of-care analyzer that were 
designed for detection of cTnI in blood and plasma samples of humans. These assays were 
expected to be useful for measurement of cTnI in bovine blood and plasma samples because 
bovine and human cTnI are > 96% homologous. (O’Brien et al. 1997)  This assumption was 
supported by results of another study (Varga et al. 2009) in which known concentrations of 
bovine cTnI were analyzed by use of an assay designed for measurement of human cTnI. 
Results of the present study indicated that the precision of the point-of-care assay for 
measurement of cTnI concentrations > 0.01 ng/mL was good, because the CV of data for such 
concentrations was < 20%. The CV was high (38%) for measurement of a low cTnI 
concentration (0.01 ng/mL) in prepared plasma standards; this finding suggested that results for 
low cTnI concentrations were not accurate. Results of other studies (Varga et al. 2009a, Varga et 
al. 2009b, Peek et al. 2008) indicate the reference range for cTnI concentrations in blood samples 
of cattle is < 0.05 to < 0.08 ng/mL. Therefore, the point-of-care analyzer evaluated in the present 
study may be useful for identification of cattle with myocardial disease, although further research 
is warranted. 
The point-of-care assay evaluated in the present study over estimated cTnI concentration, 
which may aid in data interpretation. (Abbott point of care website. Cardiac troponin /(cTnI) 
Cartridge and Test Information Sheets, 2012)  Results of this study suggested the analytic 
sensitivity of the point-of-care device for measurement of cTnI concentrations in bovine blood 
samples was 0.02 ng/mL (the lowest value that could be distinguished from a concentration of 0 
ng/mL); therefore, a cTnI concentration of 0.01 ng/mL could not be reliably differentiated from a 
concentration of 0 ng/mL. The estimated 20% and 10% functional sensitivities of the point-of-
care assay determined via calculation of CV percentages for cTnI concentrations are 0.07 and 
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0.10 ng/mL, respectively. (Abbott point of care website. Cardiac troponin /(cTnI) Cartridge and 
Test Information Sheets, 2012)  This information may aid in the understanding of a poor CV at a 
cTnI concentration of 0.01 ng/mL, and a dramatic decrease associated with values > 0.10 ng/mL. 
The point-of-care diagnostic test has improved accuracy in previously reported abnormal 
concentrations of cTnI, which are considered to be > 0.05 to > 0.08 ng/mL on the basis of 
previous reports. (Varga et al. 2009a, Varga et al. 2009b and Peek et al. 2008)  Low 
concentration results may not be precise, though would rarely cause a misclassification of a 
concentration associated with disease. 
The concentrations of cTnI determined with the point-of-care assay for blood samples 
obtained from calves in the present study were similar to those determined via a different method 
for cattle in another study. (Varga et al. 2009a)  This assay may be useful for point-of-care 
determination of cTnI concentrations for cattle. Further research may be warranted to determine 
the usefulness of this assay for identification of cattle with cardiopulmonary disease. Use of the 
point-of-care assay evaluated in the present study may allow rapid determination of cTnI 
concentrations and aid management of cattle with cardiopulmonary disease. 
 
 
Figure 3.1  Comparison of the difference of cTnI concentration as measured by the Point of 
Care method and the bench top method utilizing Bland Altman analysis.  
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Comparison of the difference of cTnI concentration as measured by the Point of Care 
method and the bench top method utilizing Bland Altman analysis.  Concentration of cTnI was 
measured on 28 healthy, 2.5 month old Holstein calves.  Data represented in the graph include: 
difference = 0.03, n = 1; difference = 0.02, n=1; difference = 0.01, n=5; difference = 0, n=12; 
difference = -0.01, n=8; difference = -0.02, n = 1. Differences of (+) value indicate 
overestimation of cTnI by the hand-held analyzer; differences of (-) value indicate 
underestimation by the hand-held analyzer as compared to the immunoassay method of analysis. 
 
 
 
Table 3.1 Concentrations of cTnI in prepared bovine plasma standard samples determined 
by use of a point-of-care assay. 
Known cTnI 
concentration in 
standard (ng/mL) 
Mean ±  SD measured concentration 
(ng/mL) 
P value* CV (%) 
0 0 ± 0 — — 
19 
 
0.01 0.015 ± 0.006 0.136 38 
0.025 0.068 ± 0.010 0.001 19 
0.05 0.078 ± 0.010 0.003 12 
0.1 0.120 ± 0.020 0.03 16 
0.25 0.296 ± 0.030 0.03 11 
0.5 0.702 ± 0.050 0.001 7 
1 1.502 ± 0.050 0.009 10 
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Chapter 4 - Biophysical Profiling of calves with experimentally 
induced Mycoplasma bovis pneumonia 
  Introduction 
Bovine respiratory disease complex (BRDC) has a major impact on cattle health and 
economic performance in the cattle industry.  The annual cost of BRDC to the United States 
cattle industry exceeds 3 billion dollars annually and is believed to be the most frequent cause of 
animal death. (Griffin et al. 1997) Bovine respiratory disease complex is a multifactorial disease 
involving multiple pathogenic agents. (Apley 2006, Allen et al. 1992, Confer 2009, Poulsen et al. 
2009, Wiggins et al. 2011)  
Despite improvements in research quality and quantity, therapy for BRDC is not always 
successful. A more complete understanding of the individual’s response to BRDC may aid in 
prompt diagnosis and successful treatment of this disease. (Griffin et al. 2010)  Diagnoses of 
BRDC most often is based on visual observation and follow up examination with rectal 
temperature.  These diagnostic tests have questionable cost effectiveness for clinical 
management of the case. Clinical observations have been shown to have limitations for accurate 
detection of BRDC calves with estimated sensitivity of 62% and specificity of 63%. (White et al. 
2009) 
Mycoplasma bovis is an increasingly recognized pathogen in bovine respiratory disease 
complex. (Maunsell et al. 2011, Hanzlicek et al. 2011, Caswell et al. 2010, Maunsell et al. 2009, 
Fulton et al. 2009, Casewell et al. 2007, and Francoz et al. 2005)  In normal cattle M. bovis has 
been recovered from up to 7% of healthy calves without recent transportation history. (Casewell 
et al. 2010)  One study showed an increasing number of calves shed M. bovis after 42 days at a 
stocker unit, and the average daily gain is less in positively testing calves. (Hanzlicek et al. 2011)  
M. bovis may be a common bovine respiratory pathogen and may represent a significant 
component to BRDC.  
Limited research has been aimed at evaluating the biophysical changes that weaned 
calves experience during development of BRDC. (Hanzlicek et al. 2010) This depth of 
knowledge can be attributed to the lack of temporal control in the development of BRDC with 
respect to collection of samples and acquisition of data. Continued research is needed to aid in 
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the early identification of BRDC and to assess the severity of disease.  Biophysical profiling is 
an evaluation of multiple measurements including components of a complete blood count, 
biochemistry, cTnI and high resolution digital thermography.  Diagnosis of BRDC is challenging 
and biophysical profiling may be an accurate tool to accomplish these goals. 
Chronic respiratory disease results in right heart hypertrophy and cor pulmonale. (Angel 
et al. 1992, and Jubb et al. 1992)  This is due to chronic increased work load to the right heart.  
Acute respiratory disease may increase cardiac workload, though it is unlikely the heart would 
compensate and hypertrophy resulting in histologic changes over a short period of time.                  
The objectives of this study were to identify changes in parameters during the early 
periods of development of pneumonia, evaluate those changes most closely associated with 
pneumonia, and to determine associations with severity of disease in Holstein calves.  The 
hypothesis was that we could use biophysical profiling to identify calves suffering pneumonia 
and to associate these changes with severity of pneumonia.  A secondary objective of this study 
was to evaluate gross changes and histologic changes of each calf’s cardiac papillary muscle. 
Chronic respiratory disease is known to result in cardiac injury in cattle resulting in a syndrome 
of cor pulmonale. (Angel et al. 1992, and Jubb et al. 1992)  We hypothesized this short duration 
of pneumonia would not result in gross or histologic changes of the calves hearts. 
 Materials and Methods 
 Animals and Management 
Research included 38 Holstein bull calves and 1 Holstein heifer calf, single sourced and 
co-housed.  The research was conducted at Kansas State University and all practices followed an 
approved protocol and guidelines set forth by the animal care and use committee. (# 2949)  
All calves in this study originated from a private owner.  These calves were purchased 
and co-housed in Iowa then transported to Kansas State University.  Calves selected for inclusion 
were based on criterion of negative nasal swab culture and PCR of M. bovis, low M. bovis 
ELISA titers, and negative BVD RT PCR by ear notch.  Calves selected for trial had the lowest 
M. bovis serum antibody levels of 39 tested.  The calves included in the trial were 27 Holstien 
bull calves and 1 Holstein heifer calf.   
At arrival to the facility, all calves received 6.6 mg/kg of ceftiofur crystalline free acid at 
the left ear base to treat any other major bovine bacterial respiratory pathogen.  M. bovis is not 
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susceptible to this antibiotic.  The feeding program for all calves consisted of free choice grass 
hay and a dairy calf complete starter grain ration (Land O Lakes, Herd Maker Supreme B90, 
Shoreview, MN) throughout the study period.  The ration contained 18.0% crude protein, 3.2% 
crude fat, 1.0% calcium, and 0.5% phosphorus.  For the first week after arrival, calves were fed 
2.0 pounds of this starter ration per head per day and subsequently increased to 3.0 pounds per 
head per day for the remainder of the study.  
After an acclimation period of 14 days, calves were randomly assigned using a random 
number generator into either a treatment (M. bovis challenge) group or a control (no challenge) 
group resulting in 24 challenged calves and 4 control caves.  Challenge calves were randomly 
assigned to an inoculation method or inoculation dose with the aid of a commercial software 
program. (Excel, Microsoft Corp, Redmond WA)  Details of sample collection procedures, 
laboratory protocols, and the trial procedures used are described elsewhere. (Amrine et al. 2013 
and White et al. 2012)   
All challenged calves were housed together in a dry lot pen measuring approximately 25 
by 25 meters.  All control calves were housed approximately two hundred meters away from the 
treatment calves for the duration of the study in a similar sized dry lot pen.  All participants with 
interactions between the treatment and control group changed protective clothing between pens.  
The study concluded on trial day 14 when all calves were euthanized and necropsied.  No calves 
were euthanized or died prior to the conclusion of the trial. 
 Body Weight and Rectal Temperature 
Calves were each individually weighed on arrival to Kansas State University on day -14.  
Weights were obtained again on day 7 and day 14 of the trial.  Rectal temperatures were obtained 
on day 7 and day 14 of the trial.  
 Clinical Illness Scores 
Clinical Illness cores were performed to evaluate if the calves showed clinical signs of 
illness. One author (BCF) performed all CIS’s independently on each calf twice daily.  The 
CIS’s were performed starting 3 days prior to challenge and continuing until the evening prior to 
necropsy. These scores were assigned based on classification system below.  
Clinical Illness Score Classifications 
1=Normal 
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2=Slight illness (i.e. mild depression and/or cough)  
3=Moderate illness (i.e. severe depression, labored breathing and/or cough) 
4=Severe illness (i.e. moribund, unresponsive)  
 Blood Collection and Analysis 
Blood was collected via jugular venipuncture from each of the 28 calves on trial days 0, 7 
and 14. Blood samples were transferred to serum vacutainers (10-ml Serum blood tube, BD, 
Franklin Lakes, NJ), lithium heparin tubes, (1.3-mL lithium tube, Sarstedt, Numbrecht, 
Germany) and EDTA vacutainers. (2-mL EDTA blood tube, BD, Franklin Lakes, NJ)  Blood 
samples were submitted to the clinical pathology service for hematology (Cell-dyn 3700 
hematology analyzer (Abbott diagnostics, Abbott Park, Illinois) and serum biochemistry (Cobas 
6000 Roche diagnostics, west Sussex England) analysis. (Clinical Pathology Laboratory, College 
of Veterinary Medicine, Kansas State University, Manhattan, KS)  Hematology analysis included 
differential cell counts performed (Geisma-Wright quick stain) under direct microscope 
examination.  Total protein and fibrinogen were anaylized using a heat precipitation method.   
Blood samples collected into lithium heparin tubes (i-STAT 1 portable clinical analyzer, 
Abbott Point of Care Inc., Princeton, NJ) were used for analysis of cardiac troponin I 
concentration.  Whole blood samples were centrifuged at 2350 x g for ten minutes at 22C.  
Plasma was harvested and maintained at -80 Celsius until analyzed.  
 Infrared Thermography 
Images were captured with HRDIRT (ThermaCAM S65, FLIR Systems, Wilsonville, 
OR) of the entire orbit and muzzle separately for calculation of maximal surface temperature of 
each anatomical location on days 0, 6 and 13.  All HRDIRT images were obtained at the same 
time of day in a sheltered area to control for environmental influences. Each image was captured 
from a distance of one meter and the angle of the image was perpendicular to each respective 
anatomical location.  All images were imported into an image analysis software program. 
(ThermaCAM Researcher 2.8 Professional, FLIR Systems, Wilsonville, OR)  The orbit was 
traced and the maximum temperature determined each sample day.  The muzzle was divided at 
the level of the ventral aspect of the nares in a horizontal fashion to form a dorsal and ventral 
area of measurement.  This method has not been published previously, and was performed based 
on the author’s personal experience.  The two areas of the muzzle were traced separately and 
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were considered the dorsal nose and the ventral nose for analysis.  The maximal temperature of 
each section was used as the value for analysis. 
 Necropsy and Pulmonary Consolidation 
On day 14 each calf was humanely euthanatized with a captive bolt and a gross necropsy 
performed.  Samples of the cardiac papillary muscle and lung were obtained from each calf for 
histologic examination. Aerobic cultures and M. bovis cultures were performed on all calf lungs.  
On necropsy one calf had pericardial effusion.  This was collected and aerobically cultured. The 
heart of each calf was evaluated grossly and the papillary muscle was collected for histologic 
evaluation.  We chose this site because this is the most sensitive site for diagnosing myocardial 
injury based on the pathologist’s experience.  
 Pulmonary Consolidation Evaluation Method 
All lungs from all calves were assessed by one of the trained and experienced investigator 
(DM) using a previously validated lung scoring method. (Fajt et al. 2003)  Using this method, 
total percentage lung consolidation was determined as follows: (0.053 · cranial segment of left 
cranial lobe %) + (0.049 · caudal segment of left cranial lobe %) + (0.319 · left caudal lobe %) + 
(0.043 · accessory lobe %) + (0.352 · right caudal lobe %) + (0.061 · right middle lobe %) + 
(0.060 · caudal segment of right cranial lobe %) + (0.063 · cranial segment of right cranial lobe 
%).   Total lung consolidation was used to divide calves into two categories of lung lesions for 
statistical analysis: 1) mild lesion severity: included all calves with 10% lung consolidation or 
less, and 2) moderate lesion severity: included all calves with greater than 10% of the lung 
affected.  A 10% cutoff was established based on behavior changes from previously published 
data. (White et al. 2012)
 
 Statistics 
Statistical analysis software programs (JMP 7.0, SAS Institute Inc., Cary NC, and Excel, 
Microsoft Corp, Redmond WA) were used for data analyses.  The biophysical parameters were 
the primary outcomes of interest in this study and they were organized in accordance with 
sample day and pulmonary consolidation category. (mild, moderate)  Treatment groups and 
control groups were evaluated together to better evaluate a variety of respiratory disease severity 
with the biophysical profile.  Generalized linear models were used to determine potential 
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associations between outcomes of interest relative to study day (0,7,14), pulmonary 
consolidation category (< 10%, > 10%) and the potential interaction between these two variables.  
An effect was also included in each model to account for repeated sampling on individual calves 
over trial day.  Significance was predetermined to be a p-value of 0.05 or less. 
 Results 
All 39 calves tested for the study were found to be negative for bovine viral diarrhea 
virus and M. bovis by culture and PCR prior to the initiation of the trial. The 28 calves selected 
for this study had the lowest titers to M bovis of the total 39 calves qualified to enter the study.  
Calves selected for the trial had a 0 or +1 on the ELISA serum antibody test out of a maximum 
score of 4 These ELISA’s were compared with a positive control sample.  The calf with the 
highest percent of positive ELISA control was 29.6 with the remainder of the claves being lower. 
On day 14 of the study all calves were euthanized and received full gross necropsies. 
 Body Weight and Rectal Temperature 
Body weights and rectal temperatures were not analyzed due to incomplete collection of 
data.  The body weights were not obtained on day 0 of the trial.  Accurate comparison with other 
variables would have not been possible.  Body weights of the 4 control calves were not obtained 
on day 7.  Rectal temperatures were not obtained on day 0.  These results would be difficult to 
interpret while being incomplete.  The body weight data is presented in table 5, while the rectal 
temperature data is presented in table 6.  This is only the raw data and was not analyzed though 
provided for completeness.     
 Clinical Illness Scores 
The number of calves receiving abnormal CIS’s increased through the trial for the 24 
study calves that received an inoculation of M. bovis. Initially all CIS’s were normal, and 24 of 
the 28 calves received at least one abnormal CIS by the study’s conclusion with the 4 non 
challenged calves not receiving abnormal CIS. (Chart 1) No calf received a CIS of 4, at any point 
during the trial.  The four control calves had CIS’s of 1 for the duration of the trial, and are not 
included in Chart 1.  
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 Serum Biochemistry and Complete Blood Count 
Serum biochemistry variables that were significantly associated with sample day and 
pulmonary consolidation category or had a significant interaction can be found in table 1. 
Variables that were significantly associated with sample day include: albumin, anion gap, blood 
urea nitrogen, chloride, creatinine, globulin, glucose, HCO3, potassium, and phosphorus.  The 
variables that were significantly associated with pulmonary consolidation category include: 
albumin, anion gap, chloride, globulin, HCO3, phosphorus, and total protein. Biochemistry 
variables associated with significant interactions between trial day and lung consolidation 
category include: alb/globulin ratio, ALP, calcium and sodium. 
Complete blood count variables that were significantly associated with sample day and 
pulmonary consolidation category or had a significant interaction can be found in table 2. 
Variables that were significantly associated with sample day include: band neutrophil 
concentration, basophil concentration, hematocrit, HGB, MCHC, and RBC.  The variables that 
were significantly associated with pulmonary consolidation category include: lymphocyte 
concentration, MCH, MCHC, and RBC.  The only CBC variable that had a significant 
interaction is fibrinogen. 
 Bovine Cardiac Troponin I 
There was no apparent significant difference with pulmonary consolidation category and 
bovine cTnI. (Table 3)  The concentration of bovine cTnI was significantly associated with 
sample day. No interaction between trial day and pulmonary consolidation category was 
observed. 
 Infrared Thermography 
There was no effect of sample day or pulmonary consolidation category on orbit 
temperature as determined by thermography. (Table 3)  An effect of sample day was not 
identified with temperatures of the dorsal and ventral portions of the nose as determined by 
thermography. A significant difference was found with pulmonary consolidation category on 
both the temperatures of both the dorsal and ventral portions of the nose.  
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 Necropsy and Histology  
Gross necropsies were performed on all calves and a single veterinary pathologist 
evaluated all lungs histologically.  Individual calves may be represented with several abnormal 
finding associated with their lungs.  Pneumonia had a wide range of findings to include varying 
degrees of consolidation, exudate on the cut surface, pus in varying airways, small nodules with 
pus and fibrinous pleuritis.   No evidence of gross pneumonia with minimal airway disease was 
found histologically in 4 of the 28 calves.  Lobular bronchopneumonia was identified 
histologically in 23 of the 28 calves.  Bronchitis was identified in 21 of the 28 calves 
histologically.   
The total percent of pulmonary consolidation ranged from 0% to 54% for calves in this 
study.  Out of 28 calves, 9 were categorized as having mild pulmonary consolidation severity. (< 
10% of pulmonary consolidation, n=9)  These 9 calves had a pulmonary consolidation range of 0 
to 8% with a median of 4%, and a mean of 3.1%.  Out of 28 calves, 19 were categorized as 
having moderate pulmonary consolidation severity (> 10% pulmonary consolidation, n=19) 
These 19 calves had a pulmonary consolidation range of 12 to 54% with a median of 28% and a 
mean of 27.7%.  Histopathology revealed no abnormalities associated with the cardiac papillary 
muscle. 
 Culture 
M. bovis was successfully cultured from 26 of the 28 lung samples. The pericardial fluid 
sample yielded no growth, but this fluid was obtained from a calf that had a positive lung culture 
for M. bovis.  Microbial cultures of the 28 lung samples not including M. bovis results yielded no 
growth (n=10), Pasteurella multocida (n=18), and beta hemolytic Streptococcus sp. (n=4)  One 
lung sample that did not yield a positive M. bovis culture result did culture positive for 
Pasteurella multocida and beta hemolytic Streptococcus sp.  The second lung sample that did not 
yield a positive M. bovis culture did not yield a positive culture for any other bacteria. 
 Discussion 
Several variables in the biophysical profile changed through the development of 
respiratory disease in calves.  The majority of these variables represented statistically significant 
changes though no clinically relevant changes.  The most interesting finding in this study was an 
interaction of fibrinogen concentration with sample day and pulmonary consolidation category.  
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This variable was higher in the calves that had greater than 10% pulmonary consolidation on day 
14 of the trial.  Cardiac troponin I did demonstrate a statistically significant increase in 
concentration over the course of disease.  No significant gross or histologic changes related with 
cardiac injury were observed with the heart.  This indicates that the myocardium was injured 
during acute respiratory disease before gross or histologic changes could be noted. The induction 
model appeared to satisfactorily induce pneumonia in this study based on changes in clinical 
illness scores and lung consolidation scores of the treatment group.  
The results of serum biochemistry analysis revealed several variables where the effect of 
sampling day was modified by the level of lung consolidation.  Albumin to globulin ratio was 
not clinically significant in that it was not outside of normal reference ranges. (Smith 2009)  
Though it was statistically lower at the initiation of the study in the high pulmonary 
consolidation category calves.  Calves that became more severely diseased may have had a lower 
ability to mount as robust of a response to disease as the less severely affected calves for reasons 
that were not identified in the study’s design.  This may have been a result less globulin from 
consumption of recent unrecognized disease, or may be a genetic difference of the calf’s immune 
systems or other variables not recorded such as body weight and body condition score.   
On days 7 and 14, calves in the high pulmonary consolidation category had lower ALP 
compared to those in low pulmonary consolidation category.  Increased ALP is often found in 
young growing calves. (Thompson JC and Pauli JV 1981)   The lower ALP in the higher 
pulmonary consolidation group may be associated with a decreased anabolic state in the calves in 
the high pulmonary consolidation category, suggestive of a less robust growing calf though not 
clinically significant.  The high pulmonary consolidation category had statistically lower serum 
calcium compared to the low pulmonary consolidation category group on day 14.  Calcium is 
highly bound to albumin and serum concentrations will decrease in correlation with albumin 
concentration.  The high pulmonary consolidation category also had a statistically lower albumin 
concentration, thus this is the likely cause for the calcium concentration difference. Several other 
variables demonstrated a significant association with pulmonary consolidation category or 
sample day.  Although statistical significance was found for multiple parameters, the clinical 
significance of these differences may be limited because these values were within normal 
reference ranges. 
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 Fibrinogen is an acute phase protein, synthesized in the liver as part of the 
immune system response to infection. (Baumann et al. 1994)  Acute phase proteins including 
fibrinogen have been reported to increase in concentration in calf blood during periods of stress 
to include abrupt weaning, transportation and comingling. (Berry et al. 2004, Holland et al. 2011, 
Hickey et al. 2003, Arthington et al. 2003 and Carter et al. 2002)  Fibrinogen was significantly 
higher in the high pulmonary consolidation category calves on day 14.  The fibrinogen 
concentrations represented in this study are both statistically and clinically important as the 
concentrations for only the high pulmonary consolidation category on day 14 was greater than 
established reference ranges. (Smith et al. 2009)
  
The normal reference range is 0.1 to 0.6 g/dL 
though this is not specific for M. bovis.  
Many variables in the CBC did show a significant association with sample day or 
pulmonary consolidation category.  There may be physiologic differences present, though 
clinical importance in the remaining variables could not be identified based on established 
reference ranges. (Smith et al. 2009)  
Cardiac troponin I has been used in bovine medicine to evaluate direct cardiac and 
indirect cardiac injury. (Varga et al. 2009a, Varga et al. 2009b, Peek et al. 2008, and Mellanby et 
al. 2009) Increased cTnI has been associated with human pulmonary hypertension. (Heresi et al. 
2012)  Cardiac troponin I was chosen to evaluate indirect cardiac injury of cattle via M. bovis 
induced pneumonia.   
There was no evidence of disease on gross examination or histological examination of the 
papillary muscles of any of the hearts.  There was a statistically higher plasma concentration of 
bovine cTnI on day 14 than day 0 and day 7 in all calves.  This association of cTnI may be 
related with pulmonary hypertension, endotoxemia, or bacteremia.  These changes may not have 
been specific for the direct insult from the pulmonary hypertension experienced from respiratory 
disease.  The cTnI statistical values that were associated with day do not exceed previous 
reported reference ranges. (Varga et al. 2009a, Varga et al. 2009b, and Peek et al. 2008)  It is 
interesting that no effect was found with pulmonary consolidation category, as it is established 
that chronic suppurative pneumonia has been shown to have higher cTnI concentrations as 
compared to controls. (Mellanby et al. 2009)  Acute pneumonia may not have a dramatic effect 
on cardiac injury of cattle. Chronic pneumonia may result in fibrosis of lung parenchyma 
resulting in pulmonary hypertension and increased stress and injury to the right heart.     
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High resolution digital infrared thermography was utilized as a component of the 
biophysical profile in this study.  Changes in both orbit and nose temperatures were recoded.  
High resolution digital infrared thermography has been used in bovine medicine and research. 
(Stewart et al. 2010a, Stewart et al. 2010b, Schaefer et al. 2007, Stewart et al. 2007)  Many 
conditions have been evaluated with this modality.   High resolution digital infrared 
thermography has been shown to possess predictive value for BRDC. (Schaefer et al. 2007)  
Previous HRDIRT studies evaluating BRDC has focused on orbit temperatures and found 
temperature changes associated with respiratory disease. (Schaefer et al. 2007)  In our study no 
significant changes in orbit temperatures were identified during the course of respiratory disease.  
Our study did find a difference of nose temperatures during the course of disease.  The lower 
temperature reading of the nose in the high pulmonary consolidation category may be a sign of 
hypotension, hypovolemia or most likely a catabolic state in the high pulmonary consolidation 
category. 
 Conclusion 
Bovine Respiratory disease complex continues to be a significant disease of cattle, and 
requires continued literature to be produced to further evaluate the individual animal’s response 
to this disease.  Changes in clinical illness scores and lungs support that the pneumonia induction 
protocol was successful.  Fibrinogen is an acute phase protein that may increase with systemic 
disease.  The statistical interaction of fibrinogen may have potential clinical application with the 
pulmonary consolidation category and sample day through M. bovis induced pneumonia.  
Clinicians may be able to evaluate fibrinogen concentrations from calves with M. bovis 
pneumonia to gain a greater understanding of the severity of the individual’s pneumonia.  In this 
study, no gross or histologic cardiac abnormalities were seen indicating no major myocardium 
remodeling or gross injury.  Little literature is available on the calf’s biophysical response to 
BRDC.  In this study many biophysical parameters have shown significant interactions and 
associations with sample day and pulmonary consolidation category.  The components of the 
biophysical profile performed in this study were not successful in determining susceptibility to 
severe respiratory disease in calves, or differentiating mild from severe respiratory disease.     
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Figure 4.1  Abnormal clinical Illness score (CIS) of Holstein calves challenged with M. 
bovis pneumonia (n=24). 
 
 
Control calves (n=4) were not included in this chart and all received normal CIS’s for the 
duration of the study.  Study calves were inoculated on day 0 and were euthanized on day 14.  
An increasing total number of calves received abnormal scores with the duration of the study.   
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Figure 4.2  Fibrinogen concentration differences in low and high lung score categories 
(n=28. 
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Table 4.1 Significant Serum Biochemistry Variables from Holstein Calves Challenged with 
M. bovis Pneumonia (n=28) 
Variable Test Levels LSM P-Value 
Alb/glob 
ratio 
LungScoreXSampleDay Day 0 Low  1.11
A
 0.03 
  Day 0 High 1.28
B
  
  Day 7 Low 1.08
A
  
  Day 7 High 1.13
A
  
  Day 14 Low 1.00
A
  
  Day 14 High 0.90
A
  
ALP U/L LungScoreXSampleDay Day 0 Low  207.89
A
 0.05 
  Day 0 High 196.11
A
  
  Day 7 Low 195.56
A
  
  Day 7 High 149.05
B
  
  Day 14 Low 183.56
A
  
  Day 14 High 105.16
B
  
CA mg/dL LungScoreXSampleDay Day 0 Low  10.64
A
 0.02 
  Day 0 High 10.72
A
  
  Day 7 Low 10.74
A
  
  Day 7 High 10.55
A
  
  Day 14 Low 10.57
A
  
  Day 14 High 9.83
B
  
NA mmol/L LungScoreXSampleDay Day 0 Low  139.22
A
 0.03 
  Day 0 High 138.79
A
  
  Day 7 Low 139.33
A
  
  Day 7 High 136.79
B
  
  Day 14 Low 136.67
A
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  Day 14 High 136.47
A
  
ALBUMIN 
g/dL 
Pulmonary 
consolidation  
<10% 3.44
A
 <0.01 
  >10% 3.26
B
  
 Sample day DAY 0 3.52
A
 <.0001 
  DAY 7 3.35
B
  
  DAY 14 3.18
C
  
ANION 
GAP 
mmol/L 
Pulmonary 
consolidation  
<10% 19.70
A
 0.01 
  >10% 18.40
B
  
 Sample day DAY 0 19.80
A
 <0.01 
  DAY 7 17.70
B
  
  DAY 14 19.66
A
  
BUN mg/dL Sample day DAY 0 12.60
A
 0.04 
  DAY 7 12.25
AB
  
  DAY 14 14.00
B
  
CL mmol/L Pulmonary 
consolidation  
<10% 97.11
A
 0.05 
  >10% 96.28
B
  
 Sample day DAY 0 97.26
A
 <0.01 
  DAY 7 97.18
A
  
  DAY 14 95.65
B
  
CREAT 
mg/dL 
Sample day DAY 0 0.70
A
 0.02 
  DAY 7 0.64
B
  
  DAY 14 0.64
B 
 
GLOBULIN 
g/dL 
Pulmonary 
consolidation  
<10% 3.31
A
 0.02 
  >10% 3.04
B
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 Sample day DAY 0 2.97
A
 <0.01 
  DAY 7 3.10
A
  
  DAY 14 3.46
B
  
GLUCOSE 
mg/dL 
Sample day DAY 0 88.89
A
 <.0001 
  DAY 7 76.64
C
  
  DAY 14 82.10
B
  
HCO3 
mmol/L 
Pulmonary 
consolidation  
<10% 27.59
A
 0.04 
  >10% 28.56
B
  
 Sample day DAY 0 28.22
A
 0.01 
  DAY 7 28.90
A
  
  DAY 14 27.11
B
  
K mmol/L Sample day DAY 0 5.03
A
 <0.01 
  DAY 7 4.77
B
  
  DAY 14 4.73
B
  
PHOS 
mg/dL 
Pulmonary 
consolidation  
<10% 7.61
A
 <0.01 
  >10% 6.92
B
  
 Sample day DAY 0 7.71
A
 <0.01 
  DAY 7 7.21
B
  
  DAY 14 6.89
B
  
PROTEIN 
g/dL 
Pulmonary 
consolidation  
<10% 6.75
A
 <0.01 
  >10% 6.30
B
  
Serum biochemistries.  Significant interactions of pulmonary consolidation category and 
study day are included, along with significant differences of pulmonary consolidation category 
and study day analyzed independently.  Students T tests were utilized to determine significant 
differences between the least squared means.  P values included if 0.05 or less.     
36 
 
 
 
Table 4.2 Significant Complete Blood Count Variables from Holstein Calves Challenged 
with M. bovis Pneumonia (n=28) 
Variable Test Levels LSM P-Value 
FIBRIN g/dL LungScoreXSampleDay Day 0 Low  0.42A <0.01 
  Day 0 High 0.44A  
  Day 7 Low 0.43A  
  Day 7 High 0.47A  
  Day 14 Low 0.44A  
  
Day 14 
High 0.74B  
BAND 
CONC K/uL Sample day DAY 0 0.01A 0.02 
  DAY 7 0.00A  
  DAY 14 0.09B  
BASO 
CONC K/uL Sample day DAY 0 0.15A 0.01 
  DAY 7 0.12AB  
  DAY 14 0.07B  
HCT % Sample day DAY 0 34.32A <0.01 
  DAY 7 31.68B  
  DAY 14 31.47B  
HGB g/dL Sample day DAY 0 12.26A 0.01 
  DAY 7 11.50B  
  DAY 14 11.32B  
LYMPH 
CONC K/uL 
Pulmonary 
consolidation  <10% 5.57A 0.02 
  >10% 4.80B  
MCH pg Pulmonary <10% 11.85A 0.02 
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consolidation  
  >10% 12.28B  
MCHC g/dL 
Pulmonary 
consolidation  <10% 36.48A 0.00 
  >10% 35.81B  
 Sample day DAY 0 35.94A 0.04 
  DAY 7 36.44B  
  DAY 14 36.05AB  
MCV fL 
Pulmonary 
consolidation  <10% 32.41A <0.01 
  >10% 34.40B  
RBC M/ul 
Pulmonary 
consolidation  <10% 10.23A 0.01 
  >10% 9.38B  
 Sample day DAY 0 10.37A 0.02 
  DAY 7 9.45B  
 
Complete blood cell counts.  Significant interactions of pulmonary consolidation 
category and study day are included, along with significant differences of pulmonary 
consolidation category and study day anaylized independently.  Students T tests were utilized to 
determine significant differences between the least squared means.  P values included if 0.05 or 
less.     
38 
 
 
 
Table 4.3 Other Significant Variables from Holstein Calves Challenged with M. bovis 
Pneumonia (n=28) 
Variable Test Levels LSM P-Value 
Cardiac 
Troponin I 
ng/ml Sample day DAY 0 0.00A 0.04 
  DAY 7 0.00A  
  DAY 14 0.02B  
HRIRT Max 
Ventral 
Nose 
Celsius 
Pulmonary 
consolidation  <10% 25.82A 0.01 
  >10% 23.07B  
HRIRT Max 
Dorsal Nose 
Celsius 
Pulmonary 
consolidation  <10% 22.85A <.01 
  >10% 18.69B  
 
Bovine cardiac troponin I (cTnI), and high-resolution digital infrared thermography.  
Significant interactions of pulmonary consolidation category and study day are included, along 
with significant differences of pulmonary consolidation category and study day anaylized 
independently.  Students T tests were utilized to determine significant differences between the 
least squared means.  P values included if 0.05 or less.     
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Chapter 5 - Thesis Conclusion 
Literature of cardiac involvement with bovine respiratory disease complex remains 
sparse.  General physiologic principles have long been established which have linked chronic 
respiratory disease with heart failure in cattle.  Little is known concerning the progression of 
heart disease in early respiratory disease.   
Evaluation of bovine cardiac troponin I can be utilized as a biomarker for cardiac injury.  
This biomarker has been used extensively in human and veterinary medicine.  Advantages of the 
use of this biomarker include ease of sample collection, inexpensive, and objective 
measurements.  With the addition of a point of care method of analysis, cattle health providers 
will be presented with rapid diagnostic information.   
The first study showed that a point-of-care assay has the ability to accurately quantify and 
identify bovine cardiac troponin.  This was accomplished through in vivo and in vitro testing of 
bovine cardiac troponin I with comparison of a previously validated immunoassay.  The in vitro 
testing demonstrated the point-of-care assay’s ability to accurately identify bovine cardiac 
troponin over a wide range of clinically applicable values.  In vitro testing demonstrated the 
ability of the point-of-care assay to identify cardiac troponin I in a calf respiratory disease model.   
This point-of-care assay will allow further clinical and research evaluation of bovine cardiac 
troponin I. 
The second study evaluated the progression of bovine respiratory disease through 
objective measurements.  The most clinically applicable finding was an increase of fibrinogen 
associated with sample day and lung score category.  Many variables showed statistical changes 
over time and by lung score category though all may not be clinically relevant.  Cardiac troponin 
I did exhibit a temporal increase through the disease course.  
Bovine respiratory disease complex and associated cardiac injury remains a challenging 
endeavor for the clinician. Further evaluation of cardiac injury as a result of respiratory disease 
may provide improved prognostic information to the animal health provider.  The point-of-care 
assay will allow a rapid and objective evaluation of cardiac injury in various disease states of the 
bovid. 
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Appendix A - Holstein calf body weight data with no statistical 
evaluation 
Table A.1 Holstein calf body weight data from chapter 4 (n=28) 
ID Date Parameter Result 
1393 -14 Weight kg 87.7 
1415 -14 Weight kg 88.6 
1429 -14 Weight kg 75.5 
1430 -14 Weight kg 65.9 
1431 -14 Weight kg 83.2 
1432 -14 Weight kg 66.4 
1433 -14 Weight kg 82.3 
1434 -14 Weight kg 75.9 
1435 -14 Weight kg 82.7 
1436 -14 Weight kg 85.5 
1437 -14 Weight kg 77.7 
1438 -14 Weight kg 73.2 
1440 -14 Weight kg 72.7 
1441 -14 Weight kg 75.5 
1442 -14 Weight kg 73.2 
1443 -14 Weight kg 68.6 
1444 -14 Weight kg 75.9 
1445 -14 Weight kg 88.6 
1446 -14 Weight kg 67.3 
1447 -14 Weight kg 84.5 
1448 -14 Weight kg 61.4 
1454 -14 Weight kg 76.8 
1455 -14 Weight kg 72.7 
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1456 -14 Weight kg 91.8 
1457 -14 Weight kg 80.5 
1460 -14 Weight kg 90.9 
1462 -14 Weight kg 78.2 
1463 -14 Weight kg 75.0 
1393 7 Weight kg 96.8 
1415 7 Weight kg 92.3 
1429 7 Weight kg 88.2 
1430 7 Weight kg 70.9 
1431 7 Weight kg 93.6 
1432 7 Weight kg 78.2 
1433 7 Weight kg 88.2 
1434 7 Weight kg 92.7 
1435 7 Weight kg 96.4 
1436 7 Weight kg 95.0 
1437 7 Weight kg 94.1 
1438 7 Weight kg 85.5 
1440 7 Weight kg 91.8 
1441 7 Weight kg 83.6 
1442 7 Weight kg 83.2 
1443 7 Weight kg 79.1 
1444 7 Weight kg 90.5 
1445 7 Weight kg 106.4 
1446 7 Weight kg x 
1447 7 Weight kg x 
1448 7 Weight kg 76.4 
1454 7 Weight kg 94.5 
1455 7 Weight kg 89.5 
1456 7 Weight kg 101.8 
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1457 7 Weight kg 96.8 
1460 7 Weight kg x 
1462 7 Weight kg x 
1463 7 Weight kg 91.8 
1393 14 Weight kg 98.2 
1415 14 Weight kg 81.4 
1429 14 Weight kg 83.6 
1430 14 Weight kg 75.5 
1431 14 Weight kg 96.8 
1432 14 Weight kg 74.1 
1433 14 Weight kg 87.3 
1434 14 Weight kg 90.9 
1435 14 Weight kg 88.6 
1436 14 Weight kg 100.9 
1437 14 Weight kg 92.7 
1438 14 Weight kg 85.9 
1440 14 Weight kg 93.2 
1441 14 Weight kg 86.8 
1442 14 Weight kg 85.0 
1443 14 Weight kg 78.2 
1444 14 Weight kg 91.4 
1445 14 Weight kg 104.5 
1446 14 Weight kg 87.3 
1447 14 Weight kg 110.5 
1448 14 Weight kg 78.6 
1454 14 Weight kg 104.1 
1455 14 Weight kg 89.5 
1456 14 Weight kg 98.2 
1457 14 Weight kg 96.8 
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1460 14 Weight kg 117.3 
1462 14 Weight kg 102.3 
1463 14 Weight kg 95.9 
Body weight data of 28 Holstein calves was not analyzed due to incompleteness of data 
collection.  No data was obtained on day 0 and the control calves were not collected on day 7.  
This chart is supplied for completeness of findings.  An x indicates no data for the collection 
time. 
 
Appendix B -  Holstein calf rectal temperature data with no 
statistical evaluation 
Table B.1 Holstein calf rectal temperatures from chapter 4 (n=28) 
ID Date Parameter Result 
1456 7 Temp Celsius 35.15 
1437 7 Temp Celsius 37.88 
1445 7 Temp Celsius 37.97 
1448 7 Temp Celsius 37.99 
1443 7 Temp Celsius 38.11 
1415 7 Temp Celsius 38.50 
1393 7 Temp Celsius 38.52 
1434 7 Temp Celsius 38.54 
1457 7 Temp Celsius 38.55 
1455 7 Temp Celsius 38.61 
1441 7 Temp Celsius 38.65 
1431 7 Temp Celsius 38.69 
1454 7 Temp Celsius 38.77 
1446 7 Temp Celsius 38.83 
1463 7 Temp Celsius 38.83 
1430 7 Temp Celsius 38.87 
1440 7 Temp Celsius 38.88 
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1436 7 Temp Celsius 38.95 
1435 7 Temp Celsius 38.99 
1433 7 Temp Celsius 39.03 
1432 7 Temp Celsius 39.11 
1438 7 Temp Celsius 39.17 
1444 7 Temp Celsius 39.17 
1460 7 Temp Celsius 39.28 
1462 7 Temp Celsius 39.33 
1429 7 Temp Celsius 39.40 
1442 7 Temp Celsius 39.51 
1447 7 Temp Celsius 39.53 
1443 14 Temp Celsius 36.45 
1457 14 Temp Celsius 37.86 
1434 14 Temp Celsius 38.55 
1460 14 Temp Celsius 38.57 
1455 14 Temp Celsius 38.59 
1446 14 Temp Celsius 38.77 
1462 14 Temp Celsius 38.97 
1463 14 Temp Celsius 39.11 
1447 14 Temp Celsius 39.23 
1454 14 Temp Celsius 39.25 
1438 14 Temp Celsius 39.35 
1393 14 Temp Celsius 39.39 
1433 14 Temp Celsius 39.49 
1441 14 Temp Celsius 39.51 
1442 14 Temp Celsius 39.53 
1435 14 Temp Celsius 39.55 
1448 14 Temp Celsius 39.59 
1436 14 Temp Celsius 39.91 
53 
 
1431 14 Temp Celsius 40.03 
1437 14 Temp Celsius 40.05 
1444 14 Temp Celsius 40.17 
1456 14 Temp Celsius 40.49 
1432 14 Temp Celsius 40.51 
1440 14 Temp Celsius 40.53 
1415 14 Temp Celsius 40.65 
1429 14 Temp Celsius 40.83 
1430 14 Temp Celsius 40.95 
1445 14 Temp Celsius 41.03 
Rectal temperature data was not analyzed due to incompleteness of data collection.  No 
data was obtained on day 0.  This chart is supplied for completeness of findings.   
 
 
 
54 
 
 
 
